Physiological and Metabolic Changes During the Transition from Hyperthyroidism to Euthyroidism in Graves' Disease

Area of Science:

• Endocrinology
• Metabolomics
• Human Physiology

Background:

• The relationship between serum metabolomic profiles and physiological changes during hyperthyroidism and its treatment is not well understood.
• Graves' disease is a common cause of hyperthyroidism, and understanding metabolic shifts during treatment is crucial for patient management.

Purpose of the Study:

• To investigate the physiological, adipokine, and metabolomic changes in women with Graves' disease transitioning from hyperthyroidism to euthyroidism.
• To provide an integrated view of fuel metabolism and energy balance alterations during hyperthyroidism treatment.

Main Methods:

• Recruited 24 Chinese women (21-50 years) with newly diagnosed Graves' disease treated with thioamides.
• Measured clinical parameters (weight, body composition, energy expenditure), biochemical markers (thyroid hormones, lipids, glucose, insulin), adipokines (leptin, adiponectin), and serum metabolomics during hyperthyroidism and euthyroidism.

Main Results:

• Treatment led to significant weight gain and increased fat mass, with reduced resting energy expenditure and increased respiratory quotient.
• Lipid profiles showed increased total, LDL, and HDL cholesterol; adiponectin levels rose, while leptin remained unchanged.
• Significant reductions in various acylcarnitines were observed, indicating altered fatty acid metabolism, without changes in fat-free mass or insulin sensitivity.

Conclusions:

• Serum metabolomic profiles change in parallel with physiological shifts during the transition from hyperthyroidism to euthyroidism.
• This study offers a comprehensive understanding of metabolic and energy balance changes following hyperthyroidism treatment.